Home
About Us
About Us
Board of Directors
Scientific Advisory Board
Management Team
Careers
For Researchers
Paxalisib
EVT801
Collaborating with Kazia
Publications and Presentations
For Partners
Our Current Partners
What We Are Looking For
For Patients
Accessing Kazia Drug Candidates in Clinical Trials
Accessing Kazia Drug Candidates for Compassionate Use
Resources for Patients
For Investors
Press Releases
ASX Announcements
Delisting from ASX
How to convert unlisted shares to ADSs
SEC Filings
Corporate Presentations
Annual Reports
Financial Reports
AGM
Corporate Governance
Shareholder Services
Media Centre
Overview
Video
Coverage
Contact
Contact Us
Subscribe to email alerts
Heading &
Sub-heading can be edited through HQI
Home
>
For Investors
>
Corporate Presentations
Press Releases
ASX Announcements
Delisting from ASX
How to convert unlisted shares to ADSs
SEC Filings
Corporate Presentations
Annual Reports
Financial Reports
AGM
Corporate Governance
Shareholder Services
Corporate Presentations
12-Apr-2024
Kazia Corporate Presentation
19-Mar-2024
EVT801 Progress Update Presentation
5-Oct-2023
Presentations at upcoming scientific meetings
26-Jun-2023
Kazia Corporate Update and Corporate Presentation
9-Nov-2022
Kazia presents to Bell Potter Healthcare Conference
14-Sep-2022
Kazia presentation to HCW Bioconnect
23-Jun-2022
Kazia presentation on paxalisib for childhood brain cancer
13-Jun-2022
Kazia Therapeutics welcomes presentation of positive paxalisib data at international symposium
19-Jan-2022
Kazia Corporate Deck
12-Nov-2021
Kazia Therapeutics AGM 2021
16-Aug-2021
Kazia corporate presentation
21-Apr-2021
EVT801 in-licensing deal investor conference call recording
21-Apr-2021
EVT801 in-licensing deal investor conference call transcript
19-Apr-2021
Kazia Corporate Presentation
22-Jan-2021
Kazia presents to ShareCafe Hidden Gems webinar
5-Jan-2021
Kazia presents to HCW BIOCONNECT
14-Dec-2020
Kazia presents to LD Micro Main Event
26-Nov-2020
Kazia presentation to Bell Potter Healthcare Conference
12-Nov-2020
Kazia presents to HCW Israel conference
1-Oct-2020
Kazia Investor Presentation
15-Sep-2020
Kazia presents to H C Wainwright conference
25-Jun-2020
Kazia presents to Hidden Gems ShareCafe Investor Webinar
22-Jun-2020
Kazia presents posters at AACR
16-Jun-2020
Kazia presentation to TKIRW
1-Jun-2020
Kazia presents interim paxalisib data to ASCO
20-Apr-2020
Kazia presents to Finance News Network
13-Jan-2020
Kazia presents at Biotech Showcase
3-Dec-2019
Kazia presents to Switzer Investment Conference
13-Nov-2019
Kazia AGM presentations
31-Oct-2019
Kazia presents to AusBiotech Invest
30-Sep-2019
Kazia presents Cantrixil poster at ESMO
20-Sep-2019
Kazia presents GDC-0084 at EANO
25-Jun-2019
Kazia presents to Gold Coast Investment Showcase
1-Apr-2019
Kazia presents Cantrixil Phase I data at AACR
18-Feb-2019
Kazia presentation to Proactive Investors
7-Jan-2019
Kazia presentation to Biotech Showcase
14-Nov-2018
Kazia presentation to SNO
8-Nov-2018
AGM presentations
30-Oct-2018
Kazia presents to AusBiotech Invest
11-Oct-2018
Presentation to Finance News Network Investor Event
16-Jul-2018
Kazia Shareholder Presentation
21-Jun-2018
Kazia presents at Gold Coast Investment Showcase
19-Mar-2018
Kazia presentation to Proactive Investors CEO series
10-Jan-2018
Kazia presentation to Biotech Showcase
